abstract |
A docetaxel albumin nanoparticle pharmaceutical composition, a method for preparing the pharmaceutical composition and its use in preparing a drug for treating cancer. The pharmaceutical composition comprises docetaxel, albumin and amino acid, wherein the mass ratio of albumin to docetaxel is not more than 50, preferably 20:1 to 1:1; the mass ratio of amino acid to docetaxel is not more than 50. Less than 0.5, preferably 1:1 to 20:1. |